Skip to Content

4891 SB (Requip 0.5 mg)

Generic Name: ropinirole

Pill imprint 4891 SB has been identified as Requip 0.5 mg.

Requip is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Requip 0.5 mg 4891 SB Front
Requip 0.5 mg 4891 SB Back
Requip 0.5 mg 4891 SB
Requip 0.5 mg 4891 SB
Requip
Generic Name:
ropinirole
Imprint:
4891 SB
Strength:
0.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00007-4891
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
titanium dioxide
ferric oxide yellow
ferric oxide red
indigotindisulfonate sodium
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
35356-0523 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide